Lv11
46 积分 2023-03-27 加入
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
4小时前
已完结
Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies
1个月前
已完结
Heterogeneity of monoclonal antibodies
1个月前
已完结
C-terminal lysine processing of human immunoglobulin G2 heavy chain in vivo
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
5个月前
已完结
Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature
6个月前
已完结
Bispecific antibody combination therapies in diffuse large B‐cell lymphoma
6个月前
已完结
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma
6个月前
已完结
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
6个月前
已完结
Efficacy and safety of MRG002 monotherapy in treating patients with locally advanced or metastatic breast cancer with low HER2 expression: A multi-center, non-randomized, open-label phase II clinical trial
6个月前
已完结
皖公网安备34019202002308
